查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1993148

人工骨市場：按材料、分銷管道、應用和最終用戶分類－2026-2032年全球市場預測

Artificial Bone Market by Material, Distribution Channel, Application, End User - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 195 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

2025年人造骨市場價值18億美元，預計2026年將成長至19.1億美元，複合年成長率為5.77%，到2032年將達到26.7億美元。

主要市場統計數據
基準年 2025 18億美元
預計年份：2026年 19.1億美元
預測年份 2032 26.7億美元
複合年成長率 (%) 5.77%

本文簡要概述了不斷發展的人工骨領域，其中生物材料的進步與外科手術、監管和供應鏈的現實情況相互交織。

人工骨領域正處於生物材料創新、外科技術進步和不斷發展的醫療服務模式的交匯點。合成支架的進步、整合策略的改進以及更精準的手術器械的出現，重新定義了骨修復和重組的臨床預期。這些技術進步與微創手術需求的成長、門診服務的擴展以及對成本效益和患者長期療效日益重視的趨勢相輔相成。

生物材料、製造、臨床證據產生和供應鏈整合的創新融合如何重新定義人工骨解決方案。

該產業正在發生多項變革性變化，重塑產品設計、臨床應用和競爭格局。首先，材料科學的創新正從傳統的異體移植擴展到高性能合成解決方案，這些解決方案具有可調控的生物分解性、增強的骨誘導性和客製化的機械性能。生物活性玻璃、羥基磷灰石複合材料、聚合物共混物和磷酸三鈣配方的進步，使開發人員能夠設計出更真實地模擬活體骨骼微環境的支架。

評估關稅措施對人造骨生態系統在供應鏈、採購經濟性和籌資策略。

2025年推出的政策變化和關稅措施帶來了新的變數，企業和醫療系統必須在產業計畫中加以考慮。如果原料、成品植入或專用設備來自海外，那麼對某些醫療進口產品提高關稅將立即影響成本結構。高度依賴受影響貿易路線的機構正面臨採購複雜性增加和價格壓力增加的局面。

識別材料、臨床應用、終端用戶採納和分銷方式方面的差異化管道，以提高產品市場適用性。

市場細分揭示了每種材料、臨床應用、終端用戶和分銷管道中存在的微妙機會和風險區域。從材料角度來看，市場由生物衍生材料和合成材料所構成，同種異體移植和異質骨移植產品正與越來越多的合成替代品競爭。合成材料本身種類繁多，包括生物活性玻璃、羥基磷灰石、金屬替代品、聚合物複合複合材料和磷酸三鈣基配方，每種材料都有其獨特的操作特性、分解特性和成本影響。這些材料差異會影響外科醫生的選擇、監管核准流程和生產要求。

為了引導策略性市場進入，我們繪製了美洲、歐洲、中東和非洲以及亞太地區的創新、監管多樣性和採用趨勢圖。

區域趨勢揭示了獨特的創新中心、法規環境和商業性壓力如何影響策略。在美洲，完善的醫療保健網路、強大的臨床研究能力和成熟的報銷體系為新材料和醫療設備的快速臨床檢驗和應用提供了支援。該地區先進的醫院和門診基礎設施催生了對能夠切實改善患者療效和提升營運效率的解決方案的需求。

市場領導和創新專家如何將臨床證據、垂直整合和數位服務結合，以建立強大的競爭優勢。

如今，競爭格局正日益受到超越基本產品特性的能力所限制。主要企業和專業創新者正加大對更全面的臨床證據包的投資，構建結合支架材料和生物佐劑的多功能平台，並與臨床中心建立戰略合作夥伴關係，以加速真實世界檢驗。一些企業優先考慮垂直整合，以管理關鍵投入並降低供應中斷的風險，而其他企業則專注於敏捷的製造地和快速的產品線改進。

針對製造商和供應商的具體策略措施，以擴大招募規模、加強供應鏈並加速臨床和商業性檢驗。

產業領導企業可以採取一系列切實可行的措施來降低風險，同時利用發展動能。優先投資於兼顧生物性能和生產規模化的合成材料平台至關重要，重點關注易於操作且分解特性符合臨床需求的配方，例如生物活性玻璃、羥基磷灰石混合物、聚合物複合材料和磷酸三鈣。同時，他們還應透過有針對性的註冊研究、研究者主導的臨床研究以及與大型手術中心的合作，擴大臨床證據的積累，從而加速關鍵意見領袖（KOL）對這些技術的認可。

為了確保獲得可操作的見解，我們採用了多層次和檢驗的研究設計，結合了第二手資料的整合、對臨床醫生和採購負責人的直接訪談、供應鏈映射和情境分析。

本研究途徑整合了來自不同資訊來源的見解，並結合了多層次的調查方法，旨在檢驗商業性和臨床主題。二手研究整合了同行評審文獻、監管文件、臨床指南和公共採購公告，以建立技術和政策基準背景。一手研究包括對骨科醫生、牙醫、醫院採購負責人、門診手術中心管理人員和研究機構的研究人員進行結構化訪談和定性討論，以捕捉細微的臨床偏好和採購行為。

將材料創新、臨床檢驗和營運韌性整合到一個系統中，以確定哪種人工骨解決方案將成為治療標準。

人工骨領域正從關注基礎植入材料轉向以工程解決方案、數據驅動的證據包和穩健的商業模式為主導的格局。材料創新拓展了治療選擇，而生產和分銷方式的變革則實現了更個人化、特異性患者的照護。政策和價格的變化凸顯了供應鏈靈活性和在地化生產策略的重要性，而臨床醫生則要求提供嚴謹的真實世界證據來支持其應用。

目錄

第1章：序言

第2章：調查方法

  • 調查設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查的前提
  • 研究限制

第3章執行摘要

  • 首席體驗長觀點
  • 市場規模和成長趨勢
  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 波特五力分析
  • PESTEL 分析
  • 市場展望
  • 上市策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會映射
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：美國關稅的累積影響，2025年

第7章：人工智慧的累積影響，2025年

第8章 人工骨市場：依材料分類

  • 同種異體移植
  • 合成
    • 生物活性玻璃
    • 羥磷石灰
    • 金屬替代材料
    • 聚合物複合材料
    • 磷酸三鈣
  • 異質骨移植

第9章：人造骨市場：依通路分類

  • 直銷
  • 銷售代理
    • 電子商務合作夥伴
    • 醫療設備銷售代理
  • 線上管道
    • 製造商網站
    • 第三方平台

第10章 人工骨市場：依應用領域分類

  • 牙科
    • 植入
    • 牙周
  • 神經病學
  • 整形外科
    • 關節重組
    • 脊椎融合手術
    • 創傷修復

第11章：人工骨市場：依最終用戶分類

  • 門診手術中心
  • 牙醫診所
  • 醫院
  • 研究機構
    • 臨床研究
    • 臨床前研究

第12章 人工骨市場：依地區分類

  • 北美洲和南美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第13章：人工骨市場：依類別分類

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第14章：人造骨市場：依國家分類

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第15章：美國人工骨市場

第16章 中國人工骨市場

第17章 競爭格局

  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年
  • Advanced Medical Solutions Group plc
  • Aesculap, Inc.
  • Allosource
  • B. Braun Melsungen AG by Octane Medical Group
  • Bando Chemical Industries Ltd.
  • Baxter International, Inc.
  • Bioventus LLC
  • Bone Biologics Corp
  • ConforMIS, Inc. by restor3d
  • curasan AG
  • Exactech, Inc.
  • Globus Medical, Inc.
  • Graftys SA
  • Integra LifeSciences Holdings Corporation
  • Johnson &Johnson
  • Medtronic plc
  • NovaBone by Halma PLC
  • NuVasive, Inc.
  • Orthofix Medical Inc.
  • OssDsign AB
  • Ossur hf.
  • RTI Surgical Holdings, Inc.
  • Smith & Nephew plc
  • Stryker Corporation
  • Zimmer Biomet Holdings, Inc.
Product Code: MRR-1A1A064C02DD

The Artificial Bone Market was valued at USD 1.80 billion in 2025 and is projected to grow to USD 1.91 billion in 2026, with a CAGR of 5.77%, reaching USD 2.67 billion by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 1.80 billion
Estimated Year [2026] USD 1.91 billion
Forecast Year [2032] USD 2.67 billion
CAGR (%) 5.77%

A concise orientation to the evolving artificial bone field where biomaterial advances intersect with surgical, regulatory, and supply chain realities

The artificial bone landscape sits at the confluence of biomaterials innovation, surgical technique evolution, and shifting healthcare delivery models. Advances in synthetic scaffolds, improved biological integration strategies, and more precise surgical tools have recalibrated clinical expectations for bone repair and reconstruction. These technological developments coincide with rising demand for minimally invasive procedures, outpatient care expansion, and an increased emphasis on cost-effectiveness and long-term patient outcomes.

Clinical leaders and procurement teams now evaluate products not only for initial handling and osteoconductivity, but for demonstrated healing trajectories, infection resistance, and compatibility with adjunctive therapies such as growth factors or cell-based approaches. Regulatory scrutiny has tightened in many jurisdictions, raising the bar for robust clinical evidence and post-market surveillance. Meanwhile, supply chain resilience and manufacturing scalability have become board-level concerns as providers seek reliable partners capable of consistent quality and responsive logistics.

Against this backdrop, stakeholders must balance innovation with reproducibility. Emerging materials and digital manufacturing techniques offer promise, yet adoption hinges on clear, reproducible clinical benefits, streamlined reimbursement pathways, and practical considerations for hospitals, clinics, and ambulatory surgical centers. The following analysis synthesizes these dynamics to orient strategy across product development, market entry, and commercial execution.

How converging innovations in biomaterials, manufacturing, clinical evidence generation, and supply integration are redefining artificial bone solutions

The industry is experiencing several transformative shifts that are reshaping product design, clinical adoption, and competitive positioning. First, materials science innovations have expanded beyond traditional allografts to high-performance synthetic solutions that offer tunable biodegradation, enhanced osteoinduction, and tailored mechanical properties. Progress in bioactive glass, hydroxyapatite composites, polymer blends, and tricalcium phosphate formulations has allowed developers to engineer scaffolds that more closely mimic native bone microenvironments.

Second, manufacturing approaches such as additive manufacturing and precision machining are enabling patient-specific implants and porous architectures that optimize vascularization and load transfer. These capabilities are altering surgeon preferences by improving intraoperative fit and reducing the need for secondary procedures. Concurrently, improvements in sterilization, packaging, and cold-chain logistics have lowered infection risks and expanded the practical use of biologic-derived materials.

Third, the competitive landscape is shifting as companies prioritize vertical integration, strategic partnerships with clinical centers, and the development of consolidated data packages that include clinical outcomes, cost-effectiveness analyses, and real-world evidence. Health systems are increasingly demanding demonstrable value, creating incentives for suppliers to align product profiles with reimbursement criteria and bundled care pathways. Together, these shifts are accelerating a market evolution from commodity grafting materials to sophisticated, clinically validated therapeutic platforms.

Assessing the strategic consequences of tariff measures on supply chains, procurement economics, and sourcing strategies in the artificial bone ecosystem

Policy changes and tariff measures introduced in 2025 have introduced new variables that companies and health systems must account for in operational planning. Increased duties on certain medical imports have immediate implications for cost structures where raw materials, finished implants, or specialized instrumentation are sourced internationally. Organizations with a concentrated exposure to affected trade lanes have faced enhanced procurement complexity and pricing pressure.

In response, manufacturers and distributors are adapting by reshaping supply chains to mitigate tariff-related risk. Some entities have accelerated nearshoring of component supply, established contingency stocking strategies, or diversified supplier portfolios to reduce dependence on tariff-impacted regions. Others have reassessed their product portfolios to prioritize locally manufactured lines or to reformulate products to leverage materials with lower import sensitivity.

Clinicians and purchasing leaders are adjusting tender specifications and total-cost-of-ownership evaluations to capture the downstream effects of tariffs on inventory turnover, device availability, and contractual pricing. At the same time, tariff-driven cost inflation is driving greater emphasis on clinical differentiation and demonstrable outcome improvements to justify price adjustments. Taken together, the cumulative impact is a recalibration of commercial models, with a renewed premium on supply chain transparency, supplier flexibility, and localized manufacturing capabilities.

Uncovering differentiated pathways for materials, clinical applications, end-user adoption, and distribution modes to sharpen product and market fit

Segmentation reveals nuanced opportunity pockets and risk zones across material types, clinical applications, end users, and distribution channels. From a materials standpoint, the market is shaped by biological and synthetic options, with allograft and xenograft offerings competing alongside a growing set of synthetic alternatives. Synthetic materials themselves vary widely, including formulations based on bioactive glass, hydroxyapatite, metal substitutes, polymer composites, and tricalcium phosphate, each presenting distinct handling characteristics, degradation profiles, and cost implications. These material distinctions influence surgeon selection, regulatory pathways, and manufacturing requirements.

Application segmentation clarifies clinical demand drivers. Dental applications encompass implantology and periodontal procedures that favor smaller, highly controlled grafts and devices that integrate with dental implant workflows. Neurological uses, particularly cranioplasty, require materials optimized for contouring, infection resistance, and long-term structural support. Orthopedic applications span joint reconstruction, spinal fusion, and trauma repair, where load-bearing capacity, osteointegration speed, and compatibility with fixation hardware are paramount. Each application imposes different evidence requirements and procurement behaviors.

End-user segmentation highlights divergent purchasing dynamics and clinical priorities. Ambulatory surgical centers prioritize products that enable rapid turnover and predictable handling, while dental clinics focus on aesthetic outcomes and integration with restorative workflows. Hospitals evaluate devices across broader clinical pathways and cost frameworks, and research institutes-both clinical and preclinical-drive innovation and early-stage validation, influencing later adoption. Distribution channel segmentation reflects multiple go-to-market approaches, from direct sales relationships to distributor networks and online channels. Distributors include e-commerce partners and specialized medical device distributors, while online channels consist of manufacturer websites and third-party platforms, creating layered opportunities for outreach, service, and logistics optimization.

Mapping regional innovation, regulatory diversity, and adoption dynamics across the Americas, Europe Middle East Africa, and Asia-Pacific to guide strategic entry

Regional dynamics reveal distinct innovation centers, regulatory environments, and commercial pressures that shape strategy. In the Americas, established healthcare networks, substantial clinical research capacity, and mature reimbursement systems support rapid clinical validation and adoption of novel materials and devices. The region's sophisticated hospital and outpatient infrastructure creates demand for solutions that deliver demonstrable improvements in patient outcomes and operational efficiency.

Europe, the Middle East & Africa presents a heterogeneous landscape where regulatory harmonization efforts coexist with country-specific reimbursement and procurement practices. Manufacturers must navigate varied approval timelines and evidence expectations, while competitive tendering and cost containment policies can influence pricing strategies. Adoption in certain markets is accelerated by strong public health programs and concentrated research centers that serve as early adopters.

Asia-Pacific is characterized by rapid capacity building, both in manufacturing and clinical adoption, with several economies investing heavily in localized production and regenerative medicine research. Market trajectories in this region are driven by demographic shifts, growing private care segments, and expanding access to elective orthopedic and dental procedures. Across regions, differences in surgeon training, payer models, and supply chain infrastructure necessitate tailored commercial and regulatory strategies rather than one-size-fits-all approaches.

How market leaders and specialized innovators are combining clinical evidence, vertical integration, and digital services to create defensible positions

Competitive dynamics are increasingly defined by capabilities beyond basic product attributes. Leading firms and specialist innovators are investing in deeper clinical evidence packages, creating multifunctional platforms that combine scaffolding with biological adjuncts, and pursuing strategic partnerships with clinical centers to accelerate real-world validation. Some organizations are prioritizing vertical integration to control critical inputs and to reduce exposure to supply disruptions, while others focus on nimble manufacturing footprints and rapid iteration of product families.

Mergers and acquisitions remain an important route for accessing complementary technologies, regulatory pathways, and established distribution networks. At the same time, open innovation models and collaborative research agreements with academic centers and contract manufacturers are enabling faster translation of laboratory advances into viable commercial products. Companies that excel are those that align R&D roadmaps with clear reimbursement pathways and that build commercial teams capable of articulating value in clinical and economic terms.

Moreover, a growing number of players are investing in digital services-such as clinician training platforms, procedural planning tools, and post-market surveillance dashboards-to differentiate offerings and deepen customer relationships. Success increasingly depends on an integrated approach that combines material science, clinical evidence, supply chain reliability, and compelling commercial support.

Concrete strategic moves for manufacturers and suppliers to expand adoption, fortify supply chains, and accelerate clinical and commercial validation

Industry leaders can pursue a set of pragmatic actions to capitalize on momentum while mitigating risk. Prioritize investment in synthetic material platforms that balance biological performance with manufacturing scalability, focusing on formulations such as bioactive glass, hydroxyapatite blends, polymer composites, and tricalcium phosphate where handling and degradation profiles meet clinical needs. Concurrently, expand clinical evidence generation through targeted registries, investigator-initiated studies, and partnerships with high-volume surgical centers to accelerate acceptance among key opinion leaders.

Strengthen supply chain resilience by diversifying suppliers, exploring nearshoring options, and implementing dual-sourcing for critical inputs. Align commercial strategies with channel realities: optimize direct sales where clinical support and training drive adoption, leverage distributor networks for broader geographic reach, and develop compelling digital storefronts for repeatable, lower-complexity products. Coordinate these efforts with reimbursement-oriented health economic data to facilitate inclusion in bundled care pathways and hospital formularies.

Finally, invest in post-market surveillance and digital value-added services to capture outcomes data that support iterative product improvement and payer negotiations. In parallel, maintain flexibility in pricing and contracting to respond to tariff impacts and local procurement dynamics. These actions together create a resilient, evidence-driven commercial model capable of sustaining growth across variable regional and regulatory environments.

A layered and validated research design combining secondary synthesis, primary clinician and procurement interviews, supply chain mapping, and scenario analysis to ensure actionable insights

The research approach combined a layered methodology designed to triangulate insights from diverse sources and to validate commercial and clinical themes. Secondary research synthesized peer-reviewed literature, regulatory filings, clinical guidelines, and public procurement notices to establish baseline technical and policy contexts. Primary research included structured interviews and qualitative discussions with orthopedic and dental surgeons, hospital procurement officers, ambulatory surgical center managers, and research institute investigators to capture nuanced clinical preferences and purchasing behaviors.

Supply chain assessments mapped supplier concentrations, manufacturing footprints, and logistical constraints, while product-level analyses examined material compositions, sterilization methods, handling profiles, and documented clinical outcomes. Case studies of representative product launches and procurement decisions illuminated real-world adoption patterns and contracting dynamics. Data quality was assured through cross-validation across sources, reconciliation of conflicting inputs, and iterative stakeholder feedback.

Where appropriate, scenario analysis was used to test the sensitivity of strategic options to regulatory shifts, tariff regimes, and adoption curves. The methodology prioritized transparency in assumptions and traceability of sources to support client-specific inquiries and to facilitate reproducibility of key analytical findings.

Synthesis of how material innovation, clinical validation, and operational resilience will determine which artificial bone solutions become standard of care

The artificial bone sector is transitioning from a focus on basic graft materials to a landscape defined by engineered solutions, data-driven evidence packages, and resilient commercial models. Material innovations are expanding therapeutic options while manufacturing and distribution shifts are enabling more tailored and patient-specific care. Policy and tariff changes underscore the importance of supply chain agility and local manufacturing strategies, even as clinicians demand rigorous, real-world evidence to support adoption.

Companies that combine rigorous clinical validation with flexible manufacturing, strategic channel alignment, and strong post-market data capabilities will be best positioned to capture opportunity. Health systems and providers will favor partners who deliver consistent quality, clear value propositions, and support for operational workflows. Looking ahead, alignment between product design, regulatory strategy, and payer engagement will determine which innovations move from promising research to routine clinical practice.

The findings point toward a future in which integrated solutions-materials plus clinical services and digital tools-reshape how bone repair therapies are evaluated, procured, and delivered, creating durable commercial advantages for organizations that act decisively.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Artificial Bone Market, by Material

  • 8.1. Allograft
  • 8.2. Synthetic
    • 8.2.1. Bioactive Glass
    • 8.2.2. Hydroxyapatite
    • 8.2.3. Metal Substitute
    • 8.2.4. Polymer Composite
    • 8.2.5. Tricalcium Phosphate
  • 8.3. Xenograft

9. Artificial Bone Market, by Distribution Channel

  • 9.1. Direct Sales
  • 9.2. Distributors
    • 9.2.1. E-commerce Partners
    • 9.2.2. Medical Device Distributors
  • 9.3. Online Channels
    • 9.3.1. Manufacturer Websites
    • 9.3.2. Third Party Platforms

10. Artificial Bone Market, by Application

  • 10.1. Dental
    • 10.1.1. Implantology
    • 10.1.2. Periodontal
  • 10.2. Neurological
  • 10.3. Orthopedic
    • 10.3.1. Joint Reconstruction
    • 10.3.2. Spinal Fusion
    • 10.3.3. Trauma Repair

11. Artificial Bone Market, by End User

  • 11.1. Ambulatory Surgical Centers
  • 11.2. Dental Clinics
  • 11.3. Hospitals
  • 11.4. Research Institutes
    • 11.4.1. Clinical Research
    • 11.4.2. Preclinical Research

12. Artificial Bone Market, by Region

  • 12.1. Americas
    • 12.1.1. North America
    • 12.1.2. Latin America
  • 12.2. Europe, Middle East & Africa
    • 12.2.1. Europe
    • 12.2.2. Middle East
    • 12.2.3. Africa
  • 12.3. Asia-Pacific

13. Artificial Bone Market, by Group

  • 13.1. ASEAN
  • 13.2. GCC
  • 13.3. European Union
  • 13.4. BRICS
  • 13.5. G7
  • 13.6. NATO

14. Artificial Bone Market, by Country

  • 14.1. United States
  • 14.2. Canada
  • 14.3. Mexico
  • 14.4. Brazil
  • 14.5. United Kingdom
  • 14.6. Germany
  • 14.7. France
  • 14.8. Russia
  • 14.9. Italy
  • 14.10. Spain
  • 14.11. China
  • 14.12. India
  • 14.13. Japan
  • 14.14. Australia
  • 14.15. South Korea

15. United States Artificial Bone Market

16. China Artificial Bone Market

17. Competitive Landscape

  • 17.1. Market Concentration Analysis, 2025
    • 17.1.1. Concentration Ratio (CR)
    • 17.1.2. Herfindahl Hirschman Index (HHI)
  • 17.2. Recent Developments & Impact Analysis, 2025
  • 17.3. Product Portfolio Analysis, 2025
  • 17.4. Benchmarking Analysis, 2025
  • 17.5. Advanced Medical Solutions Group plc
  • 17.6. Aesculap, Inc.
  • 17.7. Allosource
  • 17.8. B. Braun Melsungen AG by Octane Medical Group
  • 17.9. Bando Chemical Industries Ltd.
  • 17.10. Baxter International, Inc.
  • 17.11. Bioventus LLC
  • 17.12. Bone Biologics Corp
  • 17.13. ConforMIS, Inc. by restor3d
  • 17.14. curasan AG
  • 17.15. Exactech, Inc.
  • 17.16. Globus Medical, Inc.
  • 17.17. Graftys SA
  • 17.18. Integra LifeSciences Holdings Corporation
  • 17.19. Johnson &Johnson
  • 17.20. Medtronic plc
  • 17.21. NovaBone by Halma PLC
  • 17.22. NuVasive, Inc.
  • 17.23. Orthofix Medical Inc.
  • 17.24. OssDsign AB
  • 17.25. Ossur hf.
  • 17.26. RTI Surgical Holdings, Inc.
  • 17.27. Smith & Nephew plc
  • 17.28. Stryker Corporation
  • 17.29. Zimmer Biomet Holdings, Inc.

LIST OF FIGURES

  • FIGURE 1. GLOBAL ARTIFICIAL BONE MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL ARTIFICIAL BONE MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL ARTIFICIAL BONE MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL ARTIFICIAL BONE MARKET SIZE, BY MATERIAL, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL ARTIFICIAL BONE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL ARTIFICIAL BONE MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL ARTIFICIAL BONE MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL ARTIFICIAL BONE MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL ARTIFICIAL BONE MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL ARTIFICIAL BONE MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. UNITED STATES ARTIFICIAL BONE MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 12. CHINA ARTIFICIAL BONE MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL ARTIFICIAL BONE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL ARTIFICIAL BONE MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL ARTIFICIAL BONE MARKET SIZE, BY ALLOGRAFT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL ARTIFICIAL BONE MARKET SIZE, BY ALLOGRAFT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL ARTIFICIAL BONE MARKET SIZE, BY ALLOGRAFT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL ARTIFICIAL BONE MARKET SIZE, BY SYNTHETIC, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL ARTIFICIAL BONE MARKET SIZE, BY SYNTHETIC, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL ARTIFICIAL BONE MARKET SIZE, BY SYNTHETIC, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL ARTIFICIAL BONE MARKET SIZE, BY SYNTHETIC, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL ARTIFICIAL BONE MARKET SIZE, BY BIOACTIVE GLASS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL ARTIFICIAL BONE MARKET SIZE, BY BIOACTIVE GLASS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL ARTIFICIAL BONE MARKET SIZE, BY BIOACTIVE GLASS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL ARTIFICIAL BONE MARKET SIZE, BY HYDROXYAPATITE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL ARTIFICIAL BONE MARKET SIZE, BY HYDROXYAPATITE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL ARTIFICIAL BONE MARKET SIZE, BY HYDROXYAPATITE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL ARTIFICIAL BONE MARKET SIZE, BY METAL SUBSTITUTE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL ARTIFICIAL BONE MARKET SIZE, BY METAL SUBSTITUTE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL ARTIFICIAL BONE MARKET SIZE, BY METAL SUBSTITUTE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL ARTIFICIAL BONE MARKET SIZE, BY POLYMER COMPOSITE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL ARTIFICIAL BONE MARKET SIZE, BY POLYMER COMPOSITE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL ARTIFICIAL BONE MARKET SIZE, BY POLYMER COMPOSITE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL ARTIFICIAL BONE MARKET SIZE, BY TRICALCIUM PHOSPHATE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL ARTIFICIAL BONE MARKET SIZE, BY TRICALCIUM PHOSPHATE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL ARTIFICIAL BONE MARKET SIZE, BY TRICALCIUM PHOSPHATE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL ARTIFICIAL BONE MARKET SIZE, BY XENOGRAFT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL ARTIFICIAL BONE MARKET SIZE, BY XENOGRAFT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL ARTIFICIAL BONE MARKET SIZE, BY XENOGRAFT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL ARTIFICIAL BONE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL ARTIFICIAL BONE MARKET SIZE, BY DIRECT SALES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL ARTIFICIAL BONE MARKET SIZE, BY DIRECT SALES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL ARTIFICIAL BONE MARKET SIZE, BY DIRECT SALES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL ARTIFICIAL BONE MARKET SIZE, BY DISTRIBUTORS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL ARTIFICIAL BONE MARKET SIZE, BY DISTRIBUTORS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL ARTIFICIAL BONE MARKET SIZE, BY DISTRIBUTORS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL ARTIFICIAL BONE MARKET SIZE, BY DISTRIBUTORS, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL ARTIFICIAL BONE MARKET SIZE, BY E-COMMERCE PARTNERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL ARTIFICIAL BONE MARKET SIZE, BY E-COMMERCE PARTNERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL ARTIFICIAL BONE MARKET SIZE, BY E-COMMERCE PARTNERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL ARTIFICIAL BONE MARKET SIZE, BY MEDICAL DEVICE DISTRIBUTORS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL ARTIFICIAL BONE MARKET SIZE, BY MEDICAL DEVICE DISTRIBUTORS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL ARTIFICIAL BONE MARKET SIZE, BY MEDICAL DEVICE DISTRIBUTORS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL ARTIFICIAL BONE MARKET SIZE, BY ONLINE CHANNELS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL ARTIFICIAL BONE MARKET SIZE, BY ONLINE CHANNELS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL ARTIFICIAL BONE MARKET SIZE, BY ONLINE CHANNELS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL ARTIFICIAL BONE MARKET SIZE, BY ONLINE CHANNELS, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL ARTIFICIAL BONE MARKET SIZE, BY MANUFACTURER WEBSITES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL ARTIFICIAL BONE MARKET SIZE, BY MANUFACTURER WEBSITES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL ARTIFICIAL BONE MARKET SIZE, BY MANUFACTURER WEBSITES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL ARTIFICIAL BONE MARKET SIZE, BY THIRD PARTY PLATFORMS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL ARTIFICIAL BONE MARKET SIZE, BY THIRD PARTY PLATFORMS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL ARTIFICIAL BONE MARKET SIZE, BY THIRD PARTY PLATFORMS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL ARTIFICIAL BONE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL ARTIFICIAL BONE MARKET SIZE, BY DENTAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL ARTIFICIAL BONE MARKET SIZE, BY DENTAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL ARTIFICIAL BONE MARKET SIZE, BY DENTAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL ARTIFICIAL BONE MARKET SIZE, BY DENTAL, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL ARTIFICIAL BONE MARKET SIZE, BY IMPLANTOLOGY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL ARTIFICIAL BONE MARKET SIZE, BY IMPLANTOLOGY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL ARTIFICIAL BONE MARKET SIZE, BY IMPLANTOLOGY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL ARTIFICIAL BONE MARKET SIZE, BY PERIODONTAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL ARTIFICIAL BONE MARKET SIZE, BY PERIODONTAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL ARTIFICIAL BONE MARKET SIZE, BY PERIODONTAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL ARTIFICIAL BONE MARKET SIZE, BY NEUROLOGICAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL ARTIFICIAL BONE MARKET SIZE, BY NEUROLOGICAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL ARTIFICIAL BONE MARKET SIZE, BY NEUROLOGICAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL ARTIFICIAL BONE MARKET SIZE, BY ORTHOPEDIC, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL ARTIFICIAL BONE MARKET SIZE, BY ORTHOPEDIC, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL ARTIFICIAL BONE MARKET SIZE, BY ORTHOPEDIC, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL ARTIFICIAL BONE MARKET SIZE, BY ORTHOPEDIC, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL ARTIFICIAL BONE MARKET SIZE, BY JOINT RECONSTRUCTION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL ARTIFICIAL BONE MARKET SIZE, BY JOINT RECONSTRUCTION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL ARTIFICIAL BONE MARKET SIZE, BY JOINT RECONSTRUCTION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL ARTIFICIAL BONE MARKET SIZE, BY SPINAL FUSION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL ARTIFICIAL BONE MARKET SIZE, BY SPINAL FUSION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL ARTIFICIAL BONE MARKET SIZE, BY SPINAL FUSION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL ARTIFICIAL BONE MARKET SIZE, BY TRAUMA REPAIR, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL ARTIFICIAL BONE MARKET SIZE, BY TRAUMA REPAIR, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL ARTIFICIAL BONE MARKET SIZE, BY TRAUMA REPAIR, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL ARTIFICIAL BONE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL ARTIFICIAL BONE MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 81. GLOBAL ARTIFICIAL BONE MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 82. GLOBAL ARTIFICIAL BONE MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 83. GLOBAL ARTIFICIAL BONE MARKET SIZE, BY DENTAL CLINICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 84. GLOBAL ARTIFICIAL BONE MARKET SIZE, BY DENTAL CLINICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 85. GLOBAL ARTIFICIAL BONE MARKET SIZE, BY DENTAL CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 86. GLOBAL ARTIFICIAL BONE MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 87. GLOBAL ARTIFICIAL BONE MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 88. GLOBAL ARTIFICIAL BONE MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 89. GLOBAL ARTIFICIAL BONE MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 90. GLOBAL ARTIFICIAL BONE MARKET SIZE, BY RESEARCH INSTITUTES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 91. GLOBAL ARTIFICIAL BONE MARKET SIZE, BY RESEARCH INSTITUTES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 92. GLOBAL ARTIFICIAL BONE MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2032 (USD MILLION)
  • TABLE 93. GLOBAL ARTIFICIAL BONE MARKET SIZE, BY CLINICAL RESEARCH, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 94. GLOBAL ARTIFICIAL BONE MARKET SIZE, BY CLINICAL RESEARCH, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 95. GLOBAL ARTIFICIAL BONE MARKET SIZE, BY CLINICAL RESEARCH, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 96. GLOBAL ARTIFICIAL BONE MARKET SIZE, BY PRECLINICAL RESEARCH, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 97. GLOBAL ARTIFICIAL BONE MARKET SIZE, BY PRECLINICAL RESEARCH, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 98. GLOBAL ARTIFICIAL BONE MARKET SIZE, BY PRECLINICAL RESEARCH, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 99. GLOBAL ARTIFICIAL BONE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 100. AMERICAS ARTIFICIAL BONE MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 101. AMERICAS ARTIFICIAL BONE MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 102. AMERICAS ARTIFICIAL BONE MARKET SIZE, BY SYNTHETIC, 2018-2032 (USD MILLION)
  • TABLE 103. AMERICAS ARTIFICIAL BONE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 104. AMERICAS ARTIFICIAL BONE MARKET SIZE, BY DISTRIBUTORS, 2018-2032 (USD MILLION)
  • TABLE 105. AMERICAS ARTIFICIAL BONE MARKET SIZE, BY ONLINE CHANNELS, 2018-2032 (USD MILLION)
  • TABLE 106. AMERICAS ARTIFICIAL BONE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 107. AMERICAS ARTIFICIAL BONE MARKET SIZE, BY DENTAL, 2018-2032 (USD MILLION)
  • TABLE 108. AMERICAS ARTIFICIAL BONE MARKET SIZE, BY ORTHOPEDIC, 2018-2032 (USD MILLION)
  • TABLE 109. AMERICAS ARTIFICIAL BONE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 110. AMERICAS ARTIFICIAL BONE MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2032 (USD MILLION)
  • TABLE 111. NORTH AMERICA ARTIFICIAL BONE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 112. NORTH AMERICA ARTIFICIAL BONE MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 113. NORTH AMERICA ARTIFICIAL BONE MARKET SIZE, BY SYNTHETIC, 2018-2032 (USD MILLION)
  • TABLE 114. NORTH AMERICA ARTIFICIAL BONE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 115. NORTH AMERICA ARTIFICIAL BONE MARKET SIZE, BY DISTRIBUTORS, 2018-2032 (USD MILLION)
  • TABLE 116. NORTH AMERICA ARTIFICIAL BONE MARKET SIZE, BY ONLINE CHANNELS, 2018-2032 (USD MILLION)
  • TABLE 117. NORTH AMERICA ARTIFICIAL BONE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 118. NORTH AMERICA ARTIFICIAL BONE MARKET SIZE, BY DENTAL, 2018-2032 (USD MILLION)
  • TABLE 119. NORTH AMERICA ARTIFICIAL BONE MARKET SIZE, BY ORTHOPEDIC, 2018-2032 (USD MILLION)
  • TABLE 120. NORTH AMERICA ARTIFICIAL BONE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 121. NORTH AMERICA ARTIFICIAL BONE MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2032 (USD MILLION)
  • TABLE 122. LATIN AMERICA ARTIFICIAL BONE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 123. LATIN AMERICA ARTIFICIAL BONE MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 124. LATIN AMERICA ARTIFICIAL BONE MARKET SIZE, BY SYNTHETIC, 2018-2032 (USD MILLION)
  • TABLE 125. LATIN AMERICA ARTIFICIAL BONE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 126. LATIN AMERICA ARTIFICIAL BONE MARKET SIZE, BY DISTRIBUTORS, 2018-2032 (USD MILLION)
  • TABLE 127. LATIN AMERICA ARTIFICIAL BONE MARKET SIZE, BY ONLINE CHANNELS, 2018-2032 (USD MILLION)
  • TABLE 128. LATIN AMERICA ARTIFICIAL BONE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 129. LATIN AMERICA ARTIFICIAL BONE MARKET SIZE, BY DENTAL, 2018-2032 (USD MILLION)
  • TABLE 130. LATIN AMERICA ARTIFICIAL BONE MARKET SIZE, BY ORTHOPEDIC, 2018-2032 (USD MILLION)
  • TABLE 131. LATIN AMERICA ARTIFICIAL BONE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 132. LATIN AMERICA ARTIFICIAL BONE MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2032 (USD MILLION)
  • TABLE 133. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL BONE MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 134. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL BONE MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 135. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL BONE MARKET SIZE, BY SYNTHETIC, 2018-2032 (USD MILLION)
  • TABLE 136. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL BONE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 137. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL BONE MARKET SIZE, BY DISTRIBUTORS, 2018-2032 (USD MILLION)
  • TABLE 138. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL BONE MARKET SIZE, BY ONLINE CHANNELS, 2018-2032 (USD MILLION)
  • TABLE 139. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL BONE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 140. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL BONE MARKET SIZE, BY DENTAL, 2018-2032 (USD MILLION)
  • TABLE 141. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL BONE MARKET SIZE, BY ORTHOPEDIC, 2018-2032 (USD MILLION)
  • TABLE 142. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL BONE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 143. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL BONE MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2032 (USD MILLION)
  • TABLE 144. EUROPE ARTIFICIAL BONE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 145. EUROPE ARTIFICIAL BONE MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 146. EUROPE ARTIFICIAL BONE MARKET SIZE, BY SYNTHETIC, 2018-2032 (USD MILLION)
  • TABLE 147. EUROPE ARTIFICIAL BONE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 148. EUROPE ARTIFICIAL BONE MARKET SIZE, BY DISTRIBUTORS, 2018-2032 (USD MILLION)
  • TABLE 149. EUROPE ARTIFICIAL BONE MARKET SIZE, BY ONLINE CHANNELS, 2018-2032 (USD MILLION)
  • TABLE 150. EUROPE ARTIFICIAL BONE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 151. EUROPE ARTIFICIAL BONE MARKET SIZE, BY DENTAL, 2018-2032 (USD MILLION)
  • TABLE 152. EUROPE ARTIFICIAL BONE MARKET SIZE, BY ORTHOPEDIC, 2018-2032 (USD MILLION)
  • TABLE 153. EUROPE ARTIFICIAL BONE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 154. EUROPE ARTIFICIAL BONE MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2032 (USD MILLION)
  • TABLE 155. MIDDLE EAST ARTIFICIAL BONE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 156. MIDDLE EAST ARTIFICIAL BONE MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 157. MIDDLE EAST ARTIFICIAL BONE MARKET SIZE, BY SYNTHETIC, 2018-2032 (USD MILLION)
  • TABLE 158. MIDDLE EAST ARTIFICIAL BONE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 159. MIDDLE EAST ARTIFICIAL BONE MARKET SIZE, BY DISTRIBUTORS, 2018-2032 (USD MILLION)
  • TABLE 160. MIDDLE EAST ARTIFICIAL BONE MARKET SIZE, BY ONLINE CHANNELS, 2018-2032 (USD MILLION)
  • TABLE 161. MIDDLE EAST ARTIFICIAL BONE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 162. MIDDLE EAST ARTIFICIAL BONE MARKET SIZE, BY DENTAL, 2018-2032 (USD MILLION)
  • TABLE 163. MIDDLE EAST ARTIFICIAL BONE MARKET SIZE, BY ORTHOPEDIC, 2018-2032 (USD MILLION)
  • TABLE 164. MIDDLE EAST ARTIFICIAL BONE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 165. MIDDLE EAST ARTIFICIAL BONE MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2032 (USD MILLION)
  • TABLE 166. AFRICA ARTIFICIAL BONE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 167. AFRICA ARTIFICIAL BONE MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 168. AFRICA ARTIFICIAL BONE MARKET SIZE, BY SYNTHETIC, 2018-2032 (USD MILLION)
  • TABLE 169. AFRICA ARTIFICIAL BONE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 170. AFRICA ARTIFICIAL BONE MARKET SIZE, BY DISTRIBUTORS, 2018-2032 (USD MILLION)
  • TABLE 171. AFRICA ARTIFICIAL BONE MARKET SIZE, BY ONLINE CHANNELS, 2018-2032 (USD MILLION)
  • TABLE 172. AFRICA ARTIFICIAL BONE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 173. AFRICA ARTIFICIAL BONE MARKET SIZE, BY DENTAL, 2018-2032 (USD MILLION)
  • TABLE 174. AFRICA ARTIFICIAL BONE MARKET SIZE, BY ORTHOPEDIC, 2018-2032 (USD MILLION)
  • TABLE 175. AFRICA ARTIFICIAL BONE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 176. AFRICA ARTIFICIAL BONE MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2032 (USD MILLION)
  • TABLE 177. ASIA-PACIFIC ARTIFICIAL BONE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 178. ASIA-PACIFIC ARTIFICIAL BONE MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 179. ASIA-PACIFIC ARTIFICIAL BONE MARKET SIZE, BY SYNTHETIC, 2018-2032 (USD MILLION)
  • TABLE 180. ASIA-PACIFIC ARTIFICIAL BONE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 181. ASIA-PACIFIC ARTIFICIAL BONE MARKET SIZE, BY DISTRIBUTORS, 2018-2032 (USD MILLION)
  • TABLE 182. ASIA-PACIFIC ARTIFICIAL BONE MARKET SIZE, BY ONLINE CHANNELS, 2018-2032 (USD MILLION)
  • TABLE 183. ASIA-PACIFIC ARTIFICIAL BONE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 184. ASIA-PACIFIC ARTIFICIAL BONE MARKET SIZE, BY DENTAL, 2018-2032 (USD MILLION)
  • TABLE 185. ASIA-PACIFIC ARTIFICIAL BONE MARKET SIZE, BY ORTHOPEDIC, 2018-2032 (USD MILLION)
  • TABLE 186. ASIA-PACIFIC ARTIFICIAL BONE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 187. ASIA-PACIFIC ARTIFICIAL BONE MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2032 (USD MILLION)
  • TABLE 188. GLOBAL ARTIFICIAL BONE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 189. ASEAN ARTIFICIAL BONE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 190. ASEAN ARTIFICIAL BONE MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 191. ASEAN ARTIFICIAL BONE MARKET SIZE, BY SYNTHETIC, 2018-2032 (USD MILLION)
  • TABLE 192. ASEAN ARTIFICIAL BONE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 193. ASEAN ARTIFICIAL BONE MARKET SIZE, BY DISTRIBUTORS, 2018-2032 (USD MILLION)
  • TABLE 194. ASEAN ARTIFICIAL BONE MARKET SIZE, BY ONLINE CHANNELS, 2018-2032 (USD MILLION)
  • TABLE 195. ASEAN ARTIFICIAL BONE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 196. ASEAN ARTIFICIAL BONE MARKET SIZE, BY DENTAL, 2018-2032 (USD MILLION)
  • TABLE 197. ASEAN ARTIFICIAL BONE MARKET SIZE, BY ORTHOPEDIC, 2018-2032 (USD MILLION)
  • TABLE 198. ASEAN ARTIFICIAL BONE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 199. ASEAN ARTIFICIAL BONE MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2032 (USD MILLION)
  • TABLE 200. GCC ARTIFICIAL BONE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 201. GCC ARTIFICIAL BONE MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 202. GCC ARTIFICIAL BONE MARKET SIZE, BY SYNTHETIC, 2018-2032 (USD MILLION)
  • TABLE 203. GCC ARTIFICIAL BONE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 204. GCC ARTIFICIAL BONE MARKET SIZE, BY DISTRIBUTORS, 2018-2032 (USD MILLION)
  • TABLE 205. GCC ARTIFICIAL BONE MARKET SIZE, BY ONLINE CHANNELS, 2018-2032 (USD MILLION)
  • TABLE 206. GCC ARTIFICIAL BONE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 207. GCC ARTIFICIAL BONE MARKET SIZE, BY DENTAL, 2018-2032 (USD MILLION)
  • TABLE 208. GCC ARTIFICIAL BONE MARKET SIZE, BY ORTHOPEDIC, 2018-2032 (USD MILLION)
  • TABLE 209. GCC ARTIFICIAL BONE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 210. GCC ARTIFICIAL BONE MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2032 (USD MILLION)
  • TABLE 211. EUROPEAN UNION ARTIFICIAL BONE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 212. EUROPEAN UNION ARTIFICIAL BONE MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 213. EUROPEAN UNION ARTIFICIAL BONE MARKET SIZE, BY SYNTHETIC, 2018-2032 (USD MILLION)
  • TABLE 214. EUROPEAN UNION ARTIFICIAL BONE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 215. EUROPEAN UNION ARTIFICIAL BONE MARKET SIZE, BY DISTRIBUTORS, 2018-2032 (USD MILLION)
  • TABLE 216. EUROPEAN UNION ARTIFICIAL BONE MARKET SIZE, BY ONLINE CHANNELS, 2018-2032 (USD MILLION)
  • TABLE 217. EUROPEAN UNION ARTIFICIAL BONE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 218. EUROPEAN UNION ARTIFICIAL BONE MARKET SIZE, BY DENTAL, 2018-2032 (USD MILLION)
  • TABLE 219. EUROPEAN UNION ARTIFICIAL BONE MARKET SIZE, BY ORTHOPEDIC, 2018-2032 (USD MILLION)
  • TABLE 220. EUROPEAN UNION ARTIFICIAL BONE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 221. EUROPEAN UNION ARTIFICIAL BONE MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2032 (USD MILLION)
  • TABLE 222. BRICS ARTIFICIAL BONE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 223. BRICS ARTIFICIAL BONE MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 224. BRICS ARTIFICIAL BONE MARKET SIZE, BY SYNTHETIC, 2018-2032 (USD MILLION)
  • TABLE 225. BRICS ARTIFICIAL BONE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 226. BRICS ARTIFICIAL BONE MARKET SIZE, BY DISTRIBUTORS, 2018-2032 (USD MILLION)
  • TABLE 227. BRICS ARTIFICIAL BONE MARKET SIZE, BY ONLINE CHANNELS, 2018-2032 (USD MILLION)
  • TABLE 228. BRICS ARTIFICIAL BONE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 229. BRICS ARTIFICIAL BONE MARKET SIZE, BY DENTAL, 2018-2032 (USD MILLION)
  • TABLE 230. BRICS ARTIFICIAL BONE MARKET SIZE, BY ORTHOPEDIC, 2018-2032 (USD MILLION)
  • TABLE 231. BRICS ARTIFICIAL BONE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 232. BRICS ARTIFICIAL BONE MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2032 (USD MILLION)
  • TABLE 233. G7 ARTIFICIAL BONE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 234. G7 ARTIFICIAL BONE MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 235. G7 ARTIFICIAL BONE MARKET SIZE, BY SYNTHETIC, 2018-2032 (USD MILLION)
  • TABLE 236. G7 ARTIFICIAL BONE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 237. G7 ARTIFICIAL BONE MARKET SIZE, BY DISTRIBUTORS, 2018-2032 (USD MILLION)
  • TABLE 238. G7 ARTIFICIAL BONE MARKET SIZE, BY ONLINE CHANNELS, 2018-2032 (USD MILLION)
  • TABLE 239. G7 ARTIFICIAL BONE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 240. G7 ARTIFICIAL BONE MARKET SIZE, BY DENTAL, 2018-2032 (USD MILLION)
  • TABLE 241. G7 ARTIFICIAL BONE MARKET SIZE, BY ORTHOPEDIC, 2018-2032 (USD MILLION)
  • TABLE 242. G7 ARTIFICIAL BONE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 243. G7 ARTIFICIAL BONE MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2032 (USD MILLION)
  • TABLE 244. NATO ARTIFICIAL BONE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 245. NATO ARTIFICIAL BONE MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 246. NATO ARTIFICIAL BONE MARKET SIZE, BY SYNTHETIC, 2018-2032 (USD MILLION)
  • TABLE 247. NATO ARTIFICIAL BONE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 248. NATO ARTIFICIAL BONE MARKET SIZE, BY DISTRIBUTORS, 2018-2032 (USD MILLION)
  • TABLE 249. NATO ARTIFICIAL BONE MARKET SIZE, BY ONLINE CHANNELS, 2018-2032 (USD MILLION)
  • TABLE 250. NATO ARTIFICIAL BONE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 251. NATO ARTIFICIAL BONE MARKET SIZE, BY DENTAL, 2018-2032 (USD MILLION)
  • TABLE 252. NATO ARTIFICIAL BONE MARKET SIZE, BY ORTHOPEDIC, 2018-2032 (USD MILLION)
  • TABLE 253. NATO ARTIFICIAL BONE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 254. NATO ARTIFICIAL BONE MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2032 (USD MILLION)
  • TABLE 255. GLOBAL ARTIFICIAL BONE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 256. UNITED STATES ARTIFICIAL BONE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 257. UNITED STATES ARTIFICIAL BONE MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 258. UNITED STATES ARTIFICIAL BONE MARKET SIZE, BY SYNTHETIC, 2018-2032 (USD MILLION)
  • TABLE 259. UNITED STATES ARTIFICIAL BONE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 260. UNITED STATES ARTIFICIAL BONE MARKET SIZE, BY DISTRIBUTORS, 2018-2032 (USD MILLION)
  • TABLE 261. UNITED STATES ARTIFICIAL BONE MARKET SIZE, BY ONLINE CHANNELS, 2018-2032 (USD MILLION)
  • TABLE 262. UNITED STATES ARTIFICIAL BONE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 263. UNITED STATES ARTIFICIAL BONE MARKET SIZE, BY DENTAL, 2018-2032 (USD MILLION)
  • TABLE 264. UNITED STATES ARTIFICIAL BONE MARKET SIZE, BY ORTHOPEDIC, 2018-2032 (USD MILLION)
  • TABLE 265. UNITED STATES ARTIFICIAL BONE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 266. UNITED STATES ARTIFICIAL BONE MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2032 (USD MILLION)
  • TABLE 267. CHINA ARTIFICIAL BONE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 268. CHINA ARTIFICIAL BONE MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 269. CHINA ARTIFICIAL BONE MARKET SIZE, BY SYNTHETIC, 2018-2032 (USD MILLION)
  • TABLE 270. CHINA ARTIFICIAL BONE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 271. CHINA ARTIFICIAL BONE MARKET SIZE, BY DISTRIBUTORS, 2018-2032 (USD MILLION)
  • TABLE 272. CHINA ARTIFICIAL BONE MARKET SIZE, BY ONLINE CHANNELS, 2018-2032 (USD MILLION)
  • TABLE 273. CHINA ARTIFICIAL BONE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 274. CHINA ARTIFICIAL BONE MARKET SIZE, BY DENTAL, 2018-2032 (USD MILLION)
  • TABLE 275. CHINA ARTIFICIAL BONE MARKET SIZE, BY ORTHOPEDIC, 2018-2032 (USD MILLION)
  • TABLE 276. CHINA ARTIFICIAL BONE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 277. CHINA ARTIFICIAL BONE MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2032 (USD MILLION)